What To Do If You Use Again After Treatment
DeBinge opioid transition: When travelling to DeBinge in The Bahamas for OLANI treatment, there is no requirement to complete a separate opioid-free waiting window before arrival. DeBinge uses a medically supervised 4-to-5-day buprenorphine transition. Buprenorphine is introduced to bridge the patient away from full-agonist opioids, stabilised and tapered over the first several days, and the O’Neil Long-Acting Naltrexone Implant is typically inserted around day 4 or 5 while buprenorphine is still being tapered. The planned overlap continues as buprenorphine clears and the implant gradually releases naltrexone. This pathway is clinician-supervised because mistimed naltrexone exposure can precipitate withdrawal.
Based on DeBinge’s clinical experience in The Bahamas since 2018, the implant typically provides its strongest craving and relapse-prevention support on average 9 months, while clinically meaningful opioid-receptor blockade may persist for longer, in some patients up to about 15 months. This longer blockade may continue to reduce opioid effects and overdose risk.
Ongoing recovery: The implant is not a cure. The DeBinge programme includes a full year of professional counselling after implantation to address the behavioural and psychological side of addiction.
If you use alcohol or drugs again after treatment, the first question is not whether you have failed. The first question is whether you are safe right now.
A return to substance use can feel frightening or discouraging, but one episode does not erase the recovery work already completed. The immediate priorities are safety, stopping the episode from continuing, telling someone, reconnecting with treatment and understanding what changed before the return to use.
Check for overdose, severe withdrawal, medical complications or immediate mental-health danger. Once urgent safety has been addressed, contact a treatment provider or trusted recovery support and review what needs to change in the treatment plan.
For people returning to opioids after a period of abstinence, reduced tolerance can make overdose risk especially important. The DeBinge guide on how to prevent opioid relapse after detox or rehab explains the wider prevention framework.
Prepared for Medical Review
Dr Fergus Law, BSc, MBChB, FRCPsych
Consultant Psychiatrist specialising in substance misuse and addiction psychiatry.
This educational article has been prepared for clinical review. It should not be described as medically reviewed until that review has actually been completed.
View Dr Fergus Law’s professional profile
Start With Safety, Then Rebuild the Recovery Plan
- Check immediate safety
- If opioids were used
- The first 24 hours
- Tell someone quickly
- Stop one use becoming several days
- If alcohol was used
- Cocaine and methamphetamine
- Work out what happened before use
- Reconnect with treatment
- Review medication
- If you were taking naltrexone
- What families should do
- The next seven days
- 20-question recovery check
- Frequently asked questions
- Clinical sources
First: Check Whether This Is a Medical Emergency
Before trying to understand why substance use returned, check whether the person needs urgent medical help.
If someone is unconscious, breathing abnormally, having a seizure, experiencing severe chest pain or facing another medical emergency, contact local emergency services immediately.
If You Used Opioids Again After Treatment
Opioid tolerance can fall during a period of abstinence. An amount that was previously tolerated may therefore become much more dangerous after detox, rehab, hospitalisation, incarceration or another period without regular opioid exposure.
This reduced tolerance is one of the major reasons opioid relapse after detox can carry increased overdose risk.
Regular opioid exposure
Tolerance may increase during ongoing use.
Period without opioids
Tolerance can decrease during abstinence.
Return to a previous amount
The body may no longer tolerate what it previously did.
Overdose danger
Breathing can become dangerously suppressed.
If Opioid Overdose Is Suspected
Give naloxone if available
Use an opioid-overdose reversal medication according to its instructions.
Call emergency services
Naloxone is not a substitute for emergency medical assessment.
Support breathing
Follow instructions from emergency dispatchers and provide appropriate first aid if trained.
Place the person on their side when appropriate
This can reduce choking risk in an unconscious person who is breathing.
Stay with the person
Continue monitoring until emergency personnel arrive.
A person who wakes after naloxone can become unresponsive again. Emergency assessment remains important.
What To Do in the First 24 Hours After Using Again
Stop the episode if possible
Do not treat the first use as permission to continue for the rest of the day or week.
Move to a safer environment
Get away from substances, dealers, using partners or another setting that makes continued use easier.
Tell someone
Contact a clinician, counsellor, recovery support, sponsor, family member or another trusted person.
Protect against overdose
If opioids may be involved, make naloxone available and avoid being alone.
Reconnect with treatment
Ask whether medical reassessment, medication review, additional counselling or another level of care is needed.
Avoid major decisions while intoxicated
The immediate objective is safety and stabilisation.
Its purpose is to keep a brief setback from turning into a longer and potentially more dangerous return to use.
Tell Someone Quickly, Even if You Feel Embarrassed
Shame can encourage isolation. Isolation can make continued substance use easier.
A quicker recovery response is:
Who can you contact?
A treatment provider, addiction clinician, counsellor, recovery coach, sponsor, trusted family member or another person who will help move you toward safety and treatment rather than toward more substance use.
Do Not Turn “I Used Once” Into “I Might as Well Keep Using”
A return to substance use needs attention, but it does not require the person to abandon recovery completely.
Some people experience a brief episode. Others experience several days of use or a longer recurrence. The earlier the process is interrupted, the more opportunity there is to prevent the previous pattern from becoming established again.
“I have ruined everything.”
This can turn one episode into a reason to continue.
“Something in the plan became vulnerable. Find it and change it.”
This redirects attention toward treatment and prevention.
The broader process of identifying warning signs and building protection before the next high-risk moment is covered in How to Prevent Opioid Relapse After Detox or Rehab.
If You Drink Again After Alcohol Treatment
A return to drinking should lead to reassessment rather than automatically abandoning the recovery plan.
If the episode was brief and isolated, the immediate priorities may be to stop the sequence, reconnect with support and identify what led to the drinking.
If heavy daily drinking has resumed, however, withdrawal risk becomes important.
If substantial physical dependence may have developed again, particularly in someone with previous seizures, delirium, hallucinations, severe shaking or another history of complicated withdrawal, medical assessment is important before abruptly stopping alcohol.
Treatment may need to be strengthened
- more frequent counselling;
- a different behavioural approach;
- medication such as naltrexone where appropriate;
- acamprosate or disulfiram for suitable patients;
- withdrawal management when clinically necessary;
- a more intensive level of treatment.
If You Return to Stimulant Use
Cocaine and methamphetamine can lead to intense cycles of use, sleep deprivation, anxiety, agitation and repeated craving.
Seek urgent medical help for symptoms such as:
- chest pain;
- severe shortness of breath;
- seizure;
- extreme agitation;
- severe paranoia or psychosis;
- loss of consciousness.
There is currently no FDA-approved medication specifically for stimulant use disorder. Behavioural treatment remains central, including contingency management where available.
Naloxone and opioid-overdose preparedness may therefore still be relevant when illicit cocaine or methamphetamine is being used.
Look at the Hours and Days Before You Used
Instead of asking only “Why did I use?”, reconstruct what was changing beforehand.
People
Who were you spending time with?
Place
Where were you when risk started increasing?
Emotion
What were you feeling in the hours or days beforehand?
Thought
What were you telling yourself about using?
Access
How did the substance become available?
Support
Had contact with recovery support decreased?
Treatment
Had medication or appointments been missed?
Routine
Had sleep, work, stress or daily structure changed?
The important change may have begun several days before the substance was actually used. This is why identifying opioid relapse triggers and early warning signs in advance can be valuable.
Reconnect With Treatment Instead of Starting Recovery From Zero
A return to substance use can provide information about where the previous treatment plan was insufficient.
Questions to review with a clinician include:
- Was treatment intensive enough?
- Did counselling become too infrequent?
- Was medication stopped or missed?
- Are depression, anxiety, trauma or other mental-health symptoms worsening?
- Has the home or social environment become higher risk?
- Has access to alcohol or drugs become too easy?
- Would more structured treatment be appropriate temporarily?
- Did the relapse-prevention plan actually address the trigger that occurred?
Treatment should adapt to what the return to use has revealed.
A Return to Use Does Not Automatically Mean Medication Has Failed
Substance use may return because medication was stopped, doses were missed, the treatment did not address the main substance, behavioural support was insufficient or the current medication approach needs reassessment.
For Opioid Use Disorder
Methadone
Methadone can reduce withdrawal and cravings and is an established maintenance treatment for opioid use disorder.
Buprenorphine
Buprenorphine can reduce opioid withdrawal and cravings and support continuing treatment.
Naltrexone
Naltrexone blocks opioid receptors after the patient has completed an appropriate opioid-free period.
Ongoing evidence-based treatment should be considered after detox rather than treating withdrawal management as the complete treatment plan.
Compare the options in more detail in medications used in opioid relapse prevention.
What if You Used Again While Taking Naltrexone?
If Alcohol Was Used
Drinking while taking naltrexone does not automatically mean that treatment should be abandoned. Contact the prescribing clinician or treatment team and review how much alcohol was consumed, whether drinking is continuing, medication adherence, triggers and whether additional counselling or support is needed.
If Opioids Were Used
Naltrexone blocks opioid receptors, but the blockade should never be treated as a guarantee against overdose.
Trying to overcome opioid receptor blockade by using larger opioid quantities can be extremely dangerous. Overdose vulnerability can also increase when antagonist effects decrease or treatment is discontinued and opioid tolerance has fallen.
If physical opioid dependence may have developed again, restarting naltrexone too soon can precipitate severe withdrawal. Individual clinical assessment and an appropriate opioid-free period are required.
What About a Naltrexone Implant?
Sustained-release naltrexone implants are designed to provide prolonged antagonist exposure. They do not make opioid overdose impossible and do not replace counselling, overdose planning or continuing recovery support.
Naltrexone implant formulations are not FDA-approved for routine clinical use in the United States.
The role of longer-acting antagonist treatment is discussed further in the DeBinge opioid relapse-prevention guide.
Medication Plus Continuing Recovery Support
DeBinge provides treatment in Nassau, The Bahamas. For patients considering long-acting naltrexone, suitability should be assessed individually rather than assuming an implant is appropriate for every person.
If substance use has returned after previous treatment, a consultation should examine why the previous recovery plan became vulnerable and what needs to change.
What Should Family Members Do?
Check Safety First
Look for overdose, severe withdrawal, acute psychiatric symptoms or another emergency.
Keep Naloxone Available
This is particularly important when opioid exposure is possible.
Help Reconnect With Treatment
Encourage early clinical contact rather than waiting for the situation to become more severe.
Avoid Humiliation
Shame can increase secrecy without correcting the weakness in the treatment plan.
Maintain Boundaries
Supporting recovery does not require financing substance use or accepting unsafe behaviour.
Ask What Changed
Help identify triggers, missed treatment, emotional deterioration and environmental risks.
A Seven-Day Recovery Reset
Replace the promise with specific changes in access, medication, treatment, support, routines and the trigger environment.
Use the structured opioid relapse-prevention plan as a framework for deciding what needs to change.
20-Question Post-Use Safety & Recovery Check
This educational self-check can help identify areas that deserve discussion after substance use returns. It does not diagnose relapse severity, select a medication or replace emergency assessment.
20 Questions • About 5 Minutes
Answer according to what is happening now. If an overdose or another emergency may be occurring, do not wait to complete this questionnaire.
Is the person unconscious, breathing abnormally, having a seizure or experiencing another medical emergency?
Were opioids, fentanyl or an unknown illicit substance involved?
If opioid exposure is possible, is naloxone immediately available?
Has heavy or frequent alcohol use restarted?
Is there a history of severe withdrawal, seizures, hallucinations or complicated detoxification?
Has substance use continued beyond one isolated episode?
Have you told a treatment provider or trusted recovery support what happened?
Do you currently have a clinician or treatment service you can contact?
Has prescribed addiction medication been missed, stopped or changed recently?
Have depression, anxiety, trauma, insomnia or other mental-health symptoms worsened?
Were cravings becoming stronger or more frequent before substance use returned?
Can you identify a specific person, place, event or emotion connected with the episode?
Is it currently easy to access alcohol or drugs where you live or spend time?
Have you recently reconnected with people strongly associated with previous substance use?
Has sleep, work, daily structure or self-care become less stable?
Have you been withdrawing from counselling, recovery support or supportive people?
Did you have a specific written response for this type of high-risk situation?
If naltrexone is part of treatment, has opioid use occurred or has treatment been interrupted?
Is there at least one trusted person who can help you remain connected with treatment this week?
Do you have a clear plan for what happens during the next 24 to 72 hours?
What Should You Review Next?
These results are educational. They do not diagnose relapse severity or determine which treatment or medication is appropriate.
If overdose, severe withdrawal, seizure, unconsciousness, serious chest pain or immediate self-harm danger is present, seek urgent medical help.
Returning to Use After Treatment FAQ
Does using once mean treatment failed?
No. It should be taken seriously, but one episode can be used to identify weaknesses in the current recovery plan and strengthen treatment.
Should I tell my counsellor that I used?
Yes. Accurate information allows the treatment team to assess safety and decide whether medication, counselling or the level of care needs to change.
Why is opioid use particularly dangerous after treatment?
Opioid tolerance can decrease during abstinence, meaning a previously tolerated amount may carry greater overdose risk.
What should I do if opioid overdose is suspected?
Give naloxone if available, contact emergency services, support breathing according to emergency guidance and stay with the person until help arrives.
What if naloxone wakes the person up?
Emergency assessment can still be necessary because naloxone may wear off before the opioid has left the body.
What if I drank once after alcohol treatment?
Try to stop the episode, contact support, identify the trigger and review whether the treatment plan needs to change.
Can I abruptly stop alcohol if heavy drinking has restarted?
Significant alcohol dependence can make withdrawal medically dangerous. Seek medical assessment if heavy daily drinking or a history of severe withdrawal is involved.
What if I used cocaine or methamphetamine again?
Reconnect with treatment promptly. Emergency symptoms such as chest pain, seizure, severe agitation, psychosis or loss of consciousness require urgent medical help.
Should addiction medication be stopped after a return to use?
Not automatically. Medication should be reviewed with the prescribing clinician before changes are made.
Can I restart naltrexone immediately after using opioids?
Not if physical opioid dependence may be present. Restarting naltrexone too early can precipitate severe withdrawal and requires clinical assessment.
Does naltrexone prevent every opioid overdose?
No. Attempts to overcome opioid blockade can be dangerous, and overdose vulnerability can increase after blockade declines when tolerance has been reduced.
Is naloxone the same as naltrexone?
No. Naloxone is an emergency opioid-overdose reversal medication. Naltrexone is used as a longer-term antagonist treatment for opioid or alcohol use disorder.
Do I automatically need residential rehab again?
Not necessarily. The appropriate level of care depends on the substance used, current medical risk, duration of use, withdrawal risk, mental health and the recovery environment.
How quickly should I reconnect with treatment?
As soon as practical. Early intervention can help prevent a brief episode from developing into a longer return to substance use.
What is the most important thing to do after using again?
Address immediate safety first. Then tell someone, reconnect with treatment and strengthen the part of the recovery plan that became vulnerable.
What Matters Now Is What Happens Next
The useful response is not to spend the next several days focused only on guilt about what should have happened.
Protect safety, interrupt continued substance use, reconnect with treatment and identify the part of the recovery plan that needs to become stronger.
For opioid use disorder, that may include reviewing medication, naloxone, triggers, reduced tolerance and the plan for future cravings.
Build the Prevention Plan Before the Next High-Risk Moment
Continue with DeBinge’s comprehensive guide covering opioid cravings, triggers, overdose risk, medication options, counselling, family support and practical relapse-prevention planning.
Evidence Used in This Guide
SAMHSA — Treatment and Recovery Guidance
U.S. substance-use treatment guidance covering recovery, recurrence of substance use and continued care.
NIAAA — Alcohol Treatment
U.S. guidance on alcohol use disorder, treatment, recovery and return to drinking.
CDC — Opioid Overdose Response
Guidance on recognising opioid overdose, naloxone and emergency response.
CDC — Treating Opioid Use Disorder
Current U.S. guidance on methadone, buprenorphine, naltrexone and continuing treatment after detoxification.
FDA — Medications for Opioid Use Disorder
Regulatory information covering approved medication treatments for opioid use disorder.
DailyMed — Extended-Release Naltrexone
Current U.S. prescribing information addressing opioid-free preparation, precipitated withdrawal and overdose vulnerability.
Regulatory information, prescribing information and clinical recommendations can change. Patients should confirm current information with their treating clinician and relevant regulator.
Prepared for Medical Review
Dr Fergus Law, BSc, MBChB, FRCPsych
Consultant Psychiatrist specialising in substance misuse and addiction psychiatry.
This article has been prepared as an educational resource and is awaiting formal clinical approval.
View Dr Fergus Law’s professional profile
This Page Does Not Replace Individual Medical Care
A return to substance use can range from one brief episode to a serious recurrence involving overdose, withdrawal or acute psychiatric risk. Treatment needs to reflect the actual substance, medical situation and individual circumstances.
Do not abruptly stop methadone, buprenorphine, heavy alcohol use or another prescribed medication based on this page. Medication transitions and withdrawal may require medical supervision.
If someone is unconscious, breathing abnormally, having a seizure, experiencing severe withdrawal, severe chest pain or another medical emergency, seek immediate local emergency assistance.
DeBinge is located in Nassau, The Bahamas. We do not operate a treatment facility in the United States. Naltrexone implant formulations are not FDA-approved for routine clinical use in the United States.